Newborn GBS & Infection Evaluation and Treatment: Difference between revisions
From Guide to YKHC Medical Practices
Line 7: | Line 7: | ||
<br/>'''Critical Times for Affected Patients:''' | <br/>'''Critical Times for Affected Patients:''' | ||
===Resources/References=== | ===Resources/References=== | ||
* Puopolo KM, Lynfield R, Cummings JJ; Committee on Fetus and Newborn; Committee on Infectious Diseases. [https://pediatrics.aappublications.org/content/144/2/e20191881 Management of infants at risk for group B streptococcal disease]. ''Pediatrics''. 2019;144(2):e2019188 | |||
*[[media:GBS_neonatal.pdf|Newborn Early Onset Sepsis/GBS YKHC Clinical Guideline]] | *[[media:GBS_neonatal.pdf|Newborn Early Onset Sepsis/GBS YKHC Clinical Guideline]] | ||
Revision as of 22:01, 25 January 2021
Pathophysiology:
Inheritance:
Demographics:
Signs/Symptoms:
Diagnosis:
Management:
Critical Times for Affected Patients:
Resources/References
- Puopolo KM, Lynfield R, Cummings JJ; Committee on Fetus and Newborn; Committee on Infectious Diseases. Management of infants at risk for group B streptococcal disease. Pediatrics. 2019;144(2):e2019188
- Newborn Early Onset Sepsis/GBS YKHC Clinical Guideline